BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 33390832)

  • 1. Resveratrol (3, 5, 4'-Trihydroxy-trans-Stilbene) Attenuates a Mouse Model of Multiple Sclerosis by Altering the miR-124/Sphingosine Kinase 1 Axis in Encephalitogenic T Cells in the Brain.
    Gandy KAO; Zhang J; Nagarkatti P; Nagarkatti M
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):462-477. PubMed ID: 30941623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eomesodermin expression in CD4
    Chen S; Huan X; Xu CZ; Luo SS; Zhao CB; Zhong HH; Zheng XY; Qiao K; Dong Y; Wang Y; Liu CY; Huang HP; Chen Y; Zou ZY
    CNS Neurosci Ther; 2024 Apr; 30(4):e14503. PubMed ID: 37850654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer's disease].
    Berezutsky MA; Durnova NA; Andronova TA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):22-27. PubMed ID: 38676673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation.
    Joulia E; Michieletto MF; Agesta A; Peillex C; Girault V; Le Dorze AL; Peroceschi R; Bucciarelli F; Szelechowski M; Chaubet A; Hakim N; Marrocco R; Lhuillier E; Lebeurrier M; Argüello RJ; Saoudi A; El Costa H; Adoue V; Walzer T; Sarry JE; Dejean AS
    J Exp Med; 2024 Feb; 221(2):. PubMed ID: 38189779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases.
    Kanazawa T; Sato W; Raveney BJE; Takewaki D; Kimura A; Yamaguchi H; Yokoi Y; Saika R; Takahashi Y; Fujita T; Saiki S; Tamaoka A; Oki S; Yamamura T
    Ann Neurol; 2024 Jun; 95(6):1093-1098. PubMed ID: 38516846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis.
    Priego M; Noriega L; Kalinin S; Hoffman LM; Feinstein DL; Morfini G
    J Neuroimmunol; 2023 Sep; 382():578152. PubMed ID: 37454525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis.
    Xu X; Han C; Wang P; Zhou F
    Front Neurol; 2023; 14():1149963. PubMed ID: 36970529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgo biloba in the management of the COVID-19 severity.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Batiha GE
    Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200188. PubMed ID: 35672257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
    Liu JH; Yang HL; Deng ST; Hu Z; Chen WF; Yan WW; Hou RT; Li YH; Xian RT; Xie YY; Su Y; Wu LY; Xu P; Zhu ZB; Liu X; Deng YL; Wang YB; Liu Z; Fang WY
    Acta Pharmacol Sin; 2022 Oct; 43(10):2687-2695. PubMed ID: 35296779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological mechanism of secondary-progressive multiples sclerosis and its animal model].
    Oki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):103-13. PubMed ID: 27212596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic promises of ginkgolide A: A literature-based review.
    Sarkar C; Quispe C; Jamaddar S; Hossain R; Ray P; Mondal M; Abdulwanis Mohamed Z; Sani Jaafaru M; Salehi B; Islam MT; Faizal Abdull Razis A; Martorell M; Pastene-Navarrete E; Sharifi-Rad J
    Biomed Pharmacother; 2020 Dec; 132():110908. PubMed ID: 33254431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eomesodermin in CD4
    Chen S; Zhang J; Yu WB; Zhuang JC; Xiao W; Wu ZY; Xiao BG
    Int J Biol Sci; 2021; 17(1):50-61. PubMed ID: 33390832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation.
    Yu WB; Wang Q; Chen S; Cao L; Tang J; Ma CG; Xiao W; Xiao BG
    Int Immunopharmacol; 2019 May; 70():284-294. PubMed ID: 30851709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgolide K promotes angiogenesis in a middle cerebral artery occlusion mouse model via activating JAK2/STAT3 pathway.
    Chen M; Zou W; Chen M; Cao L; Ding J; Xiao W; Hu G
    Eur J Pharmacol; 2018 Aug; 833():221-229. PubMed ID: 29890157
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.